home All News open_in_new Full Article

Interrotta la commercializzazione in Italia dello spray nasale Minirin/DDAVP 50 mcg/ml per rischio di tossicità cardiaca e riproduttiva

Interrotta la commercializzazione in Italia dello spray nasale Minirin/DDAVP 50 mcg/ml per rischio di tossicità cardiaca e riproduttiva  socialfarma


today 49 h. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics


ID: 864842545
Add Watch Country

arrow_drop_down